In the intracerebral hemorrhage (ICH) model, the deletion of HPX aggravates brain injury and intraperitoneal treatment of hemopexin can reduce the early-stage blood–brain barrier (BBB) disruption and cell death [27,28]. The gene discussed is HPX; the disease is intracerebral hemorrhage.